Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization

Authors

  • B. M. Holdovskyy State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine", Ukraine
  • I. V. Filimonova State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine", Ukraine
  • S. O. Potalov State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine", Ukraine
  • K. V. Serikov State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine", Ukraine
  • D. V. Lelyuk State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine", Ukraine
  • R. V. Filimonov State institution "Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine", Ukraine

DOI:

https://doi.org/10.34287/MMT.1(40).2019.4

Abstract

Coronary heart disease in many countries of the world, including in Ukraine, causes high rates of morbidity, disability and mortality. The study of factors affecting the occurrence, course, prognosis and effectiveness of drug therapy for coronary artery disease is important and relevant. One of such factors is the psychological disorders of the anxiety-depressive spectrum, which often occur in patients with myocardial infarction and after coronary artery bypass grafting; therefore, such patients should be carefully examined for affective disorders and receive appropriate drug therapy.

Purpose of the study. Improvement of diagnosis and optimization of patients treatment with ischemic heart disease with concomitant anxiety-depressive disorders after myocardial revascularization.

Material and methods. The results of the study are based on survey data and dynamic observation of 95 patients with coronary heart disease, postinfarction cardiosclerosis after myocardial revascularization. The patients underwent examination during the initial examination and after 12 weeks.

Results of the study and their discussion. In the study of the psychoemotional state in the patients examined after the treatment, a significant decrease in anxiety manifestations was revealed by 36,4% against the group without fluvoxamine, where there was no significant difference before and after treatment. The manifestations of depressive disorder in the fluvoxamine group significantly decreased after treatment by 45,8 (HADS) and by 47,0% (Beck), in contrast to the group without fluvoxamine, where there was no significant difference before and after treatment.

Conclusions. Thus, it has been proved that with the addition of fluvoxamine to combined therapy for patients with ischemic heart disease, postinfarction cardiosclerosis after revascularization of the myocardium shows a more pronounced decrease in the manifestations of anxiety-depressive disorder.

References

Gandzyuk V. A. Analysis of the incidence of coronary heart disease in Ukraine. Ukrainskiy kardiologicheskiy zhurnal, 2014, № 3, рр. 45–52.

Zdorik I. F. Depressive and cognitive disorders problem in papillary hypertension patients. Arhiv psihiatriyi, 2013, vol. 2, № 73, рр. 53–57.

Pogosova G. V. et al. Citalopram clinical efficacy and safety in patients with depression after previous myocardial infarction. Kardiologiya, 2003, № 1, рр. 24–30.

Kovalenko V. M., Kornatskiy V. M. Regional medical and social problems of circulatory system diseases. Dinamika ta analiz, 2013, pp. 239, (in Ukrainian).

Sokolov M. Yu., Kobilyak V. Yu., Sokolov Yu. M. The myocardium periprocedural damage in stable angina pectoris patients, depending on the method of medication protection. Ukrayinskiy kardiologichniy zhurnal, 2015, № 3, рр. 29–39.

Melnik P. S. et al. Annual report on the health status of the population, the sanitary and epidemiological situation and the results of the health care system of Ukraine. 2016 year, MOZ Ukrayini, DU «UISD MOZ Ukrayini», Kiyiv, 2017, (in Ukrainian).

Mezuk B. et al. Depression and frailty in later life: a synthetic review. Int. J. Geriatr. Psychiatry, 2012, vol. 27, iss. 9, pp. 879–892.

Moraska A. R. et al. Depression, Healthcare Utilization, and Death in Heart Failure A Community Stud. Circulation: Heart Failure, 2013, vol. 6, № 3, pp. 387–394.

Kim H. E. et al. Distressed personality without a partner enhances the risk of depression in patients with coronary heart disease. Asia-Pacific Psychiatry, 2013, vol. 5, iss. 4, pp. 284–292.

Mroczek D. K. et al. Emotional Reactivity and Mortality: Longitudinal Findings From the VA Normative Aging Study. J. Gerontol., series B, Psychol. Sci. Soc. Sci., 2015, vol. 70, № 3, pp. 398–406. DOI: 10.1093/geronb/gbt107.

Kangas J. L. et al. Examining the Moderating Effect of Depressive Symptoms on the Relation Between Exercise and Self-Efficacy During the Initiation of Regular Exercise. Health Psychology, 2015, vol. 34, № 5, pp. 556–565. DOI: 10.1037/hea0000142.

Fried E. I, Nesse R. M. Depression sumscores don’t add up: why analyzing specific depression symptoms is essential. BMC Med., 2015, vol. 13, № 72, pp. 3–11. DOI: 10.1186/s12916-015-0325-4.

Roes A. M. et al. (2014) Letter by Roest Regarding Article, «Mental Disorders Across the Adult Life Course and Future Coronary Heart Disease: Evidence for General Susceptibility». Circulation, 2014, vol. 130, № 13, pp. e.116.

Saint Onge J. M., Krueger P. M., Rogers R. G. The Relationship Between Major Depression and Nonsuicide Mortality for U.S. Adults: The Importance of Health Behaviors. J. Gerontol., series B, Psychol. Sci. Soc. Sci., 2014, vol. 69, № 4, pp. 622–632. DOI: 10.1093/geronb/gbu009.

Downloads

Published

2019-04-20

How to Cite

Holdovskyy, B. M. ., Filimonova, I. V. ., Potalov, S. O. ., Serikov, K. V. ., Lelyuk, D. V. ., & Filimonov , R. V. . (2019). Modern strategies for the treatment of psychoemotional stress in patients with heart coronary disease after myocardial revascularization. Modern Medical Technology, (1), 25–30. https://doi.org/10.34287/MMT.1(40).2019.4

Issue

Section

Original research